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I.

INTRODUCTION

The genus Staphylococcus Rosenbach, 1884 is one of
three genera in the Family Micrococcaceae.

All are Gram-

positive, aerobic and facultatively anaerobic, catalase
positive, nonmotile cocci that occur in pairs, tetrads and
clusters.

Staphylococcus, which may be distinguished from

Micrococcus and Planococcus by its ability to ferment
glucose, is the only genus in the Family Micrococcaceae of
medical importance.

I
!r

The 1957 edition of Bergey's Manual of Determinative
Bacteriology recognized two species:
and S. epidermidis.

I!

Staphylococcus aureus

A third species, S. saprophyticus,

described by Fairbrother in 1940, was accepted as a valid
species by Baird-Parker in the 1974 edition of the Manual.
The three species are distinguished by a variety of
characteristics including coagulase production, aerobic and
anaerobic utilization of mannitol, production of alpha toxin,
novobiocin sensitivity and cell wall composition.

Coagulase

production is a characteristic of all strains, except a few
mutants, of S. aureus.

S. saprophyticus is distinguished

from S. epidermidis chiefly by its resistance

t~

novobiocin.

Until recently, only the coagulase-positive staphylococci (S. aureus) were regarded as potential pathogens.
There is, however, an increasing recognition today of the
1
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infections.

Several reports have appeared in the literature

implicating these organisms as the cause of:
1.

urinary tract infections (Pereira, 1962; Roberts,
1967; Mitchell, 1968; Mabeck, 1969; Mortensen,
1969; Pulverer and Pillich, 1971; Maskell, 1974;
Meers, 1974; Digranes and Oeding, 1975; Meers et
al., 1975; Sellin et al., 1975; Nord et al., 1976;
Williams et al., 1976; Oeding and Digranes, 1977;
Pead et al., 1977; John et al., 1978; Namavar et al.,
1978).

2.

bacterial endocarditis (Brandt and Swahn, 1960;
Quinn et al., 1966; Geracia et al., 1968; Keys and
Hewitt, 1973; Speller and Mitchell, 1973).

3.

post-cardiac surgery infections (Callaghan et al.,
1961; Bruce et al., 1963; Holt, 1969 and 1971; Okies
et al., 1971; Dismukes et al., 1973; Slaughter et
al., 1973; Blouse et al., 1975; Johnson, 1976;
Oeding and Digranes, 1977; Archer, 1978; Siebert
et al. , 1978).

4.

infections of neurosurgical and cerebrospinal shunts
(Schoenbaum et al., 1975; Archer, 1978; Siebert et
al. , 1978).

Infections at these sites and of these organs by S. aureus
are known and documented in the literature.
The recent realization that coagulase-negative staphylococci are of medical importance led to a number of studies
which attempt to characterize them more adequately (BairdParker, 1965a, 1965b, 1966, and 1974; Mortensen, 1969;
Pelzer et al., 1973; Schleifer and Kocur, .1973; Mitchell
et al., 1974; Blouse et al., 1975; Digranes and Oeding, 1975;
Kloos and Schleifer, 19'75a and 1975b; Schleifer and Kloos,
1975; Kloos et al., 1976a and 1976b; Nord et al., 1976;
Oeding and Digranes, 1977; Brunet al., 1978; Namavar et al.,
1978; Jefferson and Parisi, 1979; Varaldo et al., 1980;
Wilkinson et al., 1980; Gunn et al., 1981).

These studies
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have shown that the coagulase-negative staphylococci represent a "complex" of several species.

Kloos and Schleifer,

who are credited with the major effort to characterize the
group, list (1975b) nine species:

S. epidermidis,

§.

sapro-

phyticus, S. capitis, S. cohnii, S. haemolyticus, S. hominis,
S. simulans, S. xylosus, and S. warneri.

Hajek (1976) added

a new one, S. intermedius, isolated from animals; Kloos et al.
(1976b) described S. sciuri, and Devriese et al. (1978)
transferred Micrococcus hyicus to the genus Staphylococcus,
for a total of 12 species.

Kloos and Schleifer (1975b)

introduced a simplified scheme in the form of a flow chart
(Figure 1) for routine identification of nine of these
staphylococci.
In October of 1980 I began a study of this group with
the purpose of conducting biochemical tests on clinical
isolates from Stockton, California and, hopefully, expanding
and updating the system that was introduced by Kloos and
Schleifer.

My system, henceforth referred to as the L-K

Scheme, utilizes biochemical tests already available in
clinical laboratories.

Its purpose was to determine if

the isolates used in this study can be placed in homogeneous
groups.
In December, 1981, Analytab Products, Incorporated
(API), Plainview, New York, introduced a commercial kit.
The kit, partly based on the work of Kloos and Schleifer,
is similar, in principle, to the ones introduced earlier by
API for the identification of enteric Gram-negative bacilli,

4
anaerobes, and yeasts.

It consists of 10 microcupules

containing dehydrated substrates which provide the proper
nutrients for rapid carbohydrate and enzymatic tests which
are read after five-hour incubation at 35-37 C.

The API

kit has a coding system to identify all 12 species of the
coagulase-negative group.

II.

MATERIALS AND METHODS

BACTERIAL STRAINS
Over 100 coagulase-negative strains identified as
staphylococci were obtained between October, 1980 and July,

1981 from clinical specimens at Dameron Hospital, Stockton,
California.

These strains were tested in 0-F (oxidation-

fermentation) phenol red glucose agar to eliminate members
of the genus Micrococcus.

Species of Micrococcus oxidize

but do not ferment glucose, whereas those of Staphylococcus
oxidize and ferment this sugar.

To rule out S. aureus, each

isolate was introduced into a tube containing 0.5 ml rabbit
plasma and incubated overnight to confirm its identity as
a coagulase-negative staphylococcus.

A few strains became

non-viable during this study and were eliminated.
hundred isolates remained for further testing.

One

These were

stored as pure cultures on tryptic soy agar slants at 2-8 C
for further biochemical characterization.

The 100 strains

used in the study were recovered from the following sources:
urine (29), blood (24), wound (19), eye (8), vagina (6),
burn (4), urethra (3), and miscellaneous (ear, 2; trachea, 1;
stomach, 1; nasopharynx, 1; umbilicus, 1; amniotic fluid, 1).
Three biochemical systems were used to identify the
strains:

the L-K Scheme, devised by the author, is a

5
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modification of Kloos and Schleifer's (1975b); the second
is the API Staph-Ident System; and the third is Kloos and
Schleifer's scheme.
L-K SCHEME
Biochemical Tests
The isolates were subjected to 13 biochemical tests
involving fermentation of nine sugars and sugar alcohols
(glucose, fructose, galactose, trehalose, lactose, maltose,
sucrose, mannitol, and arabinose), nitrate reduction, gelatin hydrolysis, urease production, and the Voges-Proskauer
test for the production of acetyl methyl carbinol.
Carbohydrate fermentation studies were conducted in
agar deeps prepared for each of the sugars from dehydrated
media according to the manufacturer's instructions (Difco
Laboratories, Incorporated, Detroit, Michigan).

All carbo-

hydrates, with a final concentration of each sugar of 1%,
were dispensed as three ml aliquots in 100 x 13 mm screwcap test tubes and autoclaved at 15 pounds pressure, 121 C,
for 12 minutes.

The tubes were inoculated by stab technique

and incubated at 35-37 C.

Acid production under anaerobic

conditions is evident by a change in color of the deep agar
media from red to yellow.

Results were recorded as posi-·

tive if the color change was exhibited within 48 hours.
The nitrate broth, prepared from dehydrated medium
(Difco) according to the manufacturer's instructions, was
dispensed as 12 ml aliquots into 150 x 16 screw-cap tubes

7
and

st~rilized

in the autoclave at 15 pounds pressure,

121 C, for 15 minutes.

The tubes were inoculated with a

pure culture of each strain and incubated at 35-37 C for
24 hours.

The reduction of nitrate to nitrite was deter-

mined by adding one ml of 0.8% sulfanilic acid in five normal
acetic acid and 0.5% of dimethyl-alpha-naphthyl-amine (0.5%
of alpha-naphthyl-amine in five normal acetic acid) to three
ml of the nitrate medium.

A pink or red color indicates

the presence of nitrite.

In the absence of a pink or red

color, a trace amount of pulverized zinc was added.

If the

nitrate had not been reduced, the zinc will catalyze its
reduction and a red color will appear.

If no color develops,

the complete reduction to ammonia and nitrogen has taken
place, indicating a positive test for nitrate reduction.
Gelatinase activity was observed after introducing an
inoculum to a gelatin strip (Key Scientific Products, Los
Angeles, California) in two ml of sterile distilled water in
a 75 x 10 mm sterile tube.

Gelatin hydrolysis is indicated

by the appearance within 48 hours of a digested area on
the strip and exposure of the blue color of the supporting
base.
Urease activity was determined on urea slants purchased
from Bakte-Bennett (Berkeley, California).

The surface was

streaked with each strain and incubated at 35-37 C.

The

appearance of a pink color on the slant within 48 hours,
indicating a positive reaction, results from an enzymatic
splitting of urea into ammonia and carbon dioxide and a

.I
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change in the pH of the medium to the basic side.
The production of acetyl methyl carbinol from glucose
(the Voges-Proskauer test) was determined in a broth prepared from dehydrated Methyl Red-Voges Proskauer (MR-VP)
medium (Difco) according to instructions.

Three ml aliquots

were dispensed into individual 50 x 16 mm screw-cap tubes
and autoclaved at 15 pounds pressure, 121 C, for 15 minutes.
After inoculation and incubation for 48 hours at 35-37 C,
0.4 ml of 40% potassium hydroxide and 0.6 ml of 5% alphanaphthol in absolute ethyl alcohol were added to one ml of
the suspension.

A positive reaction is indicated by the

development of a pink color within 15 minutes.
Code Number Determination
A numerical coding system was devised to characterize
the strains in the form of a four digit identification number.

Because no isolates utilized arabinose, the negative

reaction was not included in the L-K code number discussed
below.

The remaining 12 biochemical tests were divided into

four groups of three each, as shown below:
group 1
glucose fermentation
sucrose fermentation
fructose fermentation
group 3
gelatinase activity
urease activity
lactose fermentation

group 2
maltose fermentation
nitrate reduction
galactose fermentation
group 4
Voges-Proskauer test
mannitol fermentation
trehalose fermentation

9

The positive reactions are assigned numerical values of
four, two or one depending on the position of the test within
the group.

Negative tests are assigned a value of zero.

The

first digit is determined by the results for the tests in
group one.

If glucose is fermented, four points are recorded;

two points are recorded if sucrose is fermented, and one
point if fructose is fermented.

The first digit represents

the sum of these scores resulting in 7, 6, 5, 3, 1, or 0.
The second digit is determined in the same manner, using
maltose fermentation (four points), nitrate reduction (two
points),

and

galactose fermentation (one point).

Likewise,

the third digit corresponds to the results for gelatinase
activity (four points), urease activity (two points), and
lactose fermentation (one point).

The fourth digit is deter-

mined by the result for the Voges-Proskauer test (four points),
mannitol fermentation (two points), and trehalose fermentation (one point).

As an example, the following set of

reactions corresponds to the code 7574:
glucose
+

sucrose
+

fructose
+

4------_j___----1

maltose
+
4

5

+

lactose
+

4

1

7

galactose
+

-----__J___________l

7

gelatinase

nitrate

Voges
Proskauer
+
4

mannitol

trehalose
0

4

Each four digit number represents only one combination of
reactions.

Each of the 100 strains was placed into its
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representative group corresponding to the identical four
digit number, referred to hereon as the L-K code number.
The results of this study are indicated in Table I and were
used to determine the L-K code numbers of Table II.
All data was entered into the University of the Pacific's
(Stockton, California) Burrough's

B6700 large systems com-

puter by cards and interactive terminal.

The Statistical

Package for the Socia.l Sciences (SPSS) software, was used
to generate statistical analysis.

The subroutines used were

frequencies and crosstabulation.
API STAPH-IDENT SYSTEM
Biochemical Tests
The API Staph-Ident kits, purchased from Analytab
Products, Incorporated (API), Plainview, New York, consist
of strips, each containing 10 microcupules of dehydrated
substrate media.

An inoculum from each strain was intro-

duced into five ml of sterile 0.85% saline to obtain a
slightly turbid suspension.

Two or three drops of the sus-

pension were then introduced into each of the 10 microcupules
and incubated for five hours at 35-37 C under moist conditions after which the results were read and recorded.

The

microcupules in the API strip test for:
1.

hydrolysis of p-nitrophenyl-phosphate, disodium
salt (PHS)

2.

urease detection by releasing ammonia from urea (URE)

3.

hydrolysis of p-nitrophenyl-S-D-glucopyranoside (GLS)

4-7.

acid formation from mannose (MNE), mannitol (MAN),
trehalose (TRE), and salicin (SAL)

11
8.
9.
10.

hydrolysis of p-nitrophenyl-S-D-glucuronide (GLC)
utilization of arginine (ARG)
hydrolysis of 2-naphthol-S-D-galactopyranoside (NGP)

Code Number Determination
A four digit profile is derived from the set of results
obtained for each strain.

The 10 biochemical tests are

divided into the following four groups:
PHS

MNE

SAL

URE

MAN

GLC

GLS

TRE

ARG

NGP

Negative results are assigned a value of zero.

Positive

reactions are assigned a numerical value of one, two, or

f

J

four, depending upon the location within the group.

.A value

of one is assigned for the first biochemical test in each
group (PHS, MNE, SAL, and NGP).

A value of two corresponds

to the second biochemical in each group (URE, MAN, and GLC),
and a value of four is assigned for the third biochemical
in each group (GLS, TRE, and ARG).

A four digit number is

obtained by adding the values within each group.

An example

follows for the results corresponding to the number 6721:
PHS

URE

GLS

MNE

MAN

TRE

+

+

+

+

+

I

SAL

GLC

ARG

NGP

+

+

0~4

1~4

0~0

1

6

7

2

1

1

A differential chart enclosed in each box of kits allows
species identification on the basis of the profile number.
The results of species identification are indicated in Table II.

Ii
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Not included in the API strip is the sensitivity test
to five meg novobiocin, which is a useful, and sometimes
necessary test, to distinguish between S. saprophyticus and
S. hominis.
KLOOS AND SCHLEIFER'S SCHEME
Biochemical Tests
Species identification by the Kloos and Schleifer
scheme is determined by the use of a dichotomous key in the
form of a flow chart (Figure 1).

The key biochemical tests

include aerobic acid production from carbohydrates (maltose,
mannitol, xylose, arabinose, sucrose, trehalose, xylitol,
lactose, fructose, and ribose), nitrate reduction, and
hemolysis on bovine blood agar plates.

In this study, four

tests (xylose, xylitol, ribose, and hemolysis on bovine
blood agar plates) were not used because they were not
essential for definitive identification since alternate
routes would lead to the same identification.

All results

were to be read according to the flow pattern suggested by
the diagram.

III.

RESULTS

The results of the studies are shown in Tables I, II,
III, and IV.
TABLE I
The use of glucose was intended to confirm the identification of the isolates as members of the genus Staphylococcus and therefore the fermentation of this sugar by
100% of the isolates was expected.

Over 90% of the strains

fermented sucrose, fructose, and maltose, but only 71%
fermented galactose, 59% lactose, 33% trehalose, and 29%
mannitol.
by 68%.

Nitrate was reduced by 77% and gelatin hydrolyzed
Urease was produced by 70% of the isolates, and the

production of acetyl methyl carbinol (the Voges-Proskauer
test) was characteristic of 47%.

The results of these

biochemical tests were used to determine the L-K code numbers.
TABLE II
In Table II, each isolate is listed separately by L-K
code, source, and species identification by both the API
and Kloos and Schleifer schemes.
TABLE III
Table III summarizes the results of Table II.

The

12 isolates with L-K code 7774 include nine identified as
S. epidermidis by both API and Kloos and Schleifer systems.
13

14
Three isolates key to S. hominis by the API but S. epidermidis by Kloos and Schleifer's. L-K code 7770 consisted of
seven isolates, six of which key to

~·

epidermidis by both

systems, and one to S. hominis by API but S. epidermidis by
Kloos and Schleifer's.

The third group, L-K code 7764 (four

isolates) had three S. epidermidis by both systems and one
identified as S. hominis by API but S. epidermidis by Kloos
and Schleifer's.

There were three isolates with L-K code

7760, two of which were identified as S. epidermidis by
both systems, and one which keyed to S. hominis by API but
S. epidermidis by Kloos and Schleifer's.

There were three

isolates with L-K code 7714 and three with code 7710; these
six isolates keyed to S. epidermidis by both the API and
Kloos and Schleifer's. systems. Two of the three isolates
with L-K code 7463 could not be identified by API; both
were identified asS. warneri by Kloos and Schleifer's.
The third isolate keyed to S. cohnii by API but S. warneri
by Kloos and Schleifer's.

There were two isolates with

L-K code 7777, both of which keyed to S. hominis by Kloos
and Schleifer's but could not be identified by API.

One

isolate with code 7773 was identified as S. haemolyticus
by API but S. hominis by Kloos and Schleifer's; the other
isolate was S. cohnii by API but
Schleifer's.

~·

hominis by Kloos and

In the group with code 7754, one isolate was

S. epidermidis by both schemes, the other isolate was
determined to be S. capitis by API but S. epidermidis by
Kloos and Schleifer's.

Both isolates with L-K code 7753
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were identified as S. haemolyticus by API but S. hominis
by Kloos and Schleifer's.

The two isolates with L-K code

7750 were S. epidermidis by both systems.

One isolate

with code 7730 was identified as S. epidermidis by both
schemes, the other as S. hominis by API but S. epidermidis
by Kloos and Schleifer's.

There were two isolates with

L-K code 7717; both keyed to S. hominis by Kloos and
Schleifer's, one of which keyed to S. sciuri, the other
could not be identified by API.

In the group with L-K

code 7520, one isolate was considered as S. epidermidis by
both systems, one as S. saprophyticus by API but S. epidermidis by Kloos and Schleifer's.

Both isolates with code

7473 were identified as S. warneri by API but S. saprophyticus by Kloos and Schleifer's.
Forty-seven isolates had individual L-K code numbers,
nine of which keyed to S. epidermidis and one to S. hominis
by both systems.

The other 37 isolates included two that

could not be identified by either system, 17 that keyed to
one species by API, but to a different species by Kloos
and Schleifer's, and 18 unidentifiable by one or the other,
as Table III shows.
TABLE IV
The distribution of the coagulase-negative staphylococci was also studied by source of specimen.
are tabulated (Table IV).

The results

Urine, blood, and wound collec-

tively harbored 72 of the 100 isolates.

Eleven of 29

16
from wound (37.9%), nine of 24 from blood (37.5%), and nine
of 19 from wound (47.4%) keyed to S. epidermidis by both API
and Kloos and Schleifer's scheme.

Forty-three isolates

(59.7%) were in non-agreement at the species level.

Table IV

shows also that 15 of the 43 isolates (34.9%) could not be
identified by API, and four were non-identifiable by Kloos
and Schleifer's.

Six isolates are identified as S. capitis

(one isolate), S. cohnii (four isolates), and S. sciuri
(one isolate) by the API.

These species do not occur in the

collection when Kloos and Schleifer's scheme is used.

S.

sciuri was not described until 1976 and, therefore, does
not appear in Kloos and Schleifer's scheme; however, S.
capitis and S. cohnii are included in that system.

Kloos

and Schleifer's key identifies four isolates as S. simulans,
but this species is not encountered when the API scheme is
used.

Equally interesting, the 13 isolates identified by

the API as S. hominis do not include any of the 11 S. hominis
species identified by Kloos and Schleifer's.

The same is

true of S. haemolyticus (two vs five), S. saprophyticus
(three vs two), and S. warneri (two vs five); the first
number in the parentheses is identified as that species by
API, the second number by Kloos and Schleifer's.

Two

isolates identified as S. epidermidis by API were not identified as that species by Kloos and Schleifer's.

IV.

DISCUSSION

The results of the study as they appear in Tables II
and III show the inadequacy of the API system.

Of the 100

isolates, 40 keyed to S. epidermidis and one to S. hominis
by both the API and Kloos and Schleifer's systems.

Fifty-

nine did not key out to a common species.
The API identified 18 of the 59 as S. hominis, 14 of
which keyed to S. epidermidis, one to S. haemolyticus, and
three unidentifiable by Kloos and Schleifer's scheme.

Six

of the isolates keyed to S. cohnii by API; according to
Kloos and Schleifer's, these

were~·

hominis (three),

S. warneri (two), and S. haemolyticus (one).

Four isolates

were identified as S. saprophyticus by API; three of these
were S. epidermidis, and one S. haemolyticus by Kloos and
Schleifer's.

Three isolates identified as S. epidermidis by

API were S. simulans, S. hominis and one unidentifiable by
Kloos and Schleifer's.

All three isolates identified as

S. haemolyticus by API were identified S. hominis by Kloos
and Schleifer's.

Of the two isolates which keyed to S.

capitis by API, one was identified as S. epidermidis and one
was unidentifiable by Kloos and Schleifer's.

The two iso-

lates identified as S. warneri by API keyed to S. saprophyticus by Kloos and Schleifer's.

One isolate identified

as S. sciuri by API keyed to S. hominis by Kloos and
Schleifer's.

Of the 20 isolates which could not be identified

17

18
by API, eight were§. hominis,

five~·

warneri, three

S. simulans, and two S. haemolyticus by Kloos and Schleifer's;
two could not be identified by Kloos and Schleifer's either.
Similar problems concerning definitive identification were
encountered by Oeding and Digranes (1977).
Oeding and Digranes (1977) used two schemes to identify
128 urinary isolates.

One scheme utilized five criteria

(aerobic acid production from sucrose, trehalose, and mannitol, phosphatase production, and sensitivity to novobiocin;
the other utilized three (acid production from mannitol,
phosphatase production, and dihydrolysis of arginine).
Using the first scheme, they found 29 isolates of S. epidermidis, 45 of S. saprophyticus, and nine of S. cohnii;
45 could not be identified by this method.

With the second

scheme, 38 were identified as S. epidermidis and 55 as S.
saprophyticus; S. cohnii was not found and 35 were nonidentifiable.

These authors are not clear in their presen-

tation of the data; for example, it is not known whether
the 29 isolates identified as S. epidermidis by the first
scheme were among the 38 identified as that species by the
second..

The same is true of the isolates identified as

S. saprophyticus.

The 45 isolates that could not be iden-

tified by the first scheme were then keyed out, using Kloos
and Schleifer's.

They found that they could speciate some

of the isolates to S. haemolyticus (six), S. hominis (11),
and S. capitis (two).

Nineteen of the 45 keyed

to~·

simulans or S. warneri (which could not be separated), and

19
seven remained unidentified.

However, the species pre-

viously identified were not subjected to the scheme of
Kloos and Schleifer to determine the accuracy of their
identification.

Oeding and Digranes subjected 70 isolates

from blood and pus to the same testing.

When utilizing

the first scheme, 41 of the isolates were identified as
S. epidermidis; 29 isolates could not be classified, but
when using Kloos and Schleifer's key, were found to be
~·

haemolyticus (seven), S. hominis (eight), S. capitis

(one), S. simulans or S. warneri (four), and not identifiable (nine).

The results, using the second method, were

S. epidermidis (35), S. saprophyticus (two), and not
classified (33).
Only three types of clinical specimens had isolates
in relatively large number.

Therefore, the discussion will

center on these isolates from urine, blood, and wound.

As

far as it can be determined, only three reports (Oeding
and Digranes, 1977; Namavar et al., 1978; and John et al.,
19~8)

are found in the literature that speciate the coagu-

lase-negative staphylococci from urine, blood, and skin/
wound.
Studies dealing with the distribution of coagulasenegative staphylococci in clinical material face the problem of proper identification of isolates.

My results, as

well as those of Oeding and Digranes (1977), clearly show
that the identity of an isolate depends on what scheme is
used for its identification.

Namavar et al.

(1978) reached
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a similar conclusion.

There is also some doubt as to the

validity of all the species reported by Kloos and Schleifer
(1975b).

Namavar et al.

(1978) state, "Although the Kloos

and Schleifer scheme provides more information about biochemical characters, doubts are expressed about the validity
of some of the species so delineated."

Kloos and Schleifer's

scheme, the API, the schemes used by Oeding and Digranes
(1977) and by Namavar et al. (1978) are not the only ones
that appear in the literature.

Therefore, to make any useful

conclusions one must compare studies utilizing similar systems.

As far as it can be determined, there is only one

study, that of John et al. (1978), with which we can compare
our results, since they also utilized Kloos and Schleifer's
scheme.

There are no results published which utilized the

API in determining the distribution of coagulase-negative
staphylococci in clinical specimens, since the API has just
become available (December, 1981).

Therefore, the discussion

will center on the comparison with the results of John et
al.

(1978), who reported on urinary isolates.
In the study by John et al.

(1978), of 138 coagulase-

negative staphylococci from urine, 53% were S. epidermidis,
12% S. hominis, 10% S. haemolyticus, 7% S. cohnii, 5% S.
saprophyticus, 5% S. simulans, 4% S. capitis, 1% S. xylosus,
and 4% unidentifiable.

Utilizing the scheme of Kloos and

Schleifer, my results show that 62% of the isolates were
S. epidermidis, 10% S. hominis, 7% S. haemolyticus, 7% S.
saprophyticus, 3% S. simulans, 7% S. warneri, and 3%
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unidentifiable; there were no S. cohnii, S. capitis, or
S. xylosus.

The results of the two studies are somewhat

similar, the greatest differences being the presence or
absence of S. cohnii, S. capitis, S. xylosus, and S. warneri.
There are no reports in the literature which studied
the distribution of coagulase-negative staphylococci in
wounds or blood that utilized the scheme of Kloos and
Schleifer.

Therefore, the work of other investigators in

this area could not be compared with my results.

In my

study, based only on identification by Kloos and Schleifer's,
the 24 isolates from blood were identified as S. epidermidis
(42%), S. hominis (17%),

~·

warneri (13%), S. haemolyticus

(8%), and S. simulans (8%); 13% were not identifiable.

The

19 isolates from wound were identified as S. epidermidis
(68%), S. hominis (21%), S. haemolyticus (5%), and S.
simulans (5%).
It may be concluded from this study that Kloos and
Schleifer's scheme is more adequate than the API StaphIdent System for the identification of coagulase-negative
staphylococci.

This is evident by the fact that only 7%

of the isolates could not be speciated by this scheme,
compared with 20% by the API.

Dameron Hospital's (Stockton,

California) microbiology laboratory personnel, according to
F. M. Nahhas (personal communication), have experienced
similar problems with the API Staph-Ident System.

The

system introduced by the author is also inadequate, judging
by the large number of "groups" obtained.

The largest

22
group, L-K code 7774, had 12 isolates; L-K code 7770 had
seven, 14 groups consisted of two to four isolates each,
and 47 isolates had individual code numbers.

This study,

on the other hand, is the first one to show the inadequacy
of the API Staph-Ident system.

It is clear that further

biochemical characterization of the coagulase-negative
staphylococci is needed.

It may also be concluded that no

one species of coagulase-negative staphylococci is restricted
to any one clinical source.

V.

SUMMARY

One hundred isolates of coagulase-negative staphylococci, obtained from Dameron Hospital (Stockton, California) between October, 1980 and July, 1981, were tested
by three different biochemical schemes.

The data was

entered into a computer (the Burrough's

B6700 model)

using SPSS.

The results obtained from this study confirm

observations of earlier investigators that the coagulasenegative staphylococci represent a heterogeneous group of
species.

The study also concludes that the present schemes

used in speciation are inadequate but that the scheme of
Kloos and Schleifer is more satisfactory than the API
Staph-Ident System.
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Figure 1.

Scheme of Kloos and Schleifer (1975) for identification of human coagulase-negative staphylococci.
Heavy solid lines denote the major routes and light
dashed lines denote the minor routes of character
types leading to the various species positions.
Abbreviations: Mal, maltose; Mtl, D-mannitol;
Xyl, D(+) xylose; Ara, L(+) arabinose; Sue, sucrose;
Tre, D(+) trehalose; Xtl, xylitol; Lac, alphalactose; Fru, beta-D(-)fructose; Rib, D(-) ribose;
Nit, nitrate; Hem, hemolysis.
Symbols: +, positive, +, weak; -, negative.
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Table I
The L-K Scheme

per cent of
strains with
PO sJ... t.
:.1 ve reac t:ion

biochemical test

100

glucose fermentation

96

sucrose fermentation

95

fructose fermentation

94

maltose fermentation

77
71
68

nitrate reduction

70

presence of urease

59

lactose fermentation

47

Voges-Proskauer test

29

mannitol fermentation

33

trehalose fermentation

/{.,

galactose fermentation
gelatin hydrolysis

J
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Table II
Identification of Coagulase-Negative Staphylococci by
L-K, API, and Kloos and Schleifer Schemes

-

-

Cede

Source

7774

urine

02 imlates)

wound
eye
vagina
burn
ear
urine
7770
(7 isolates)
blood
eye
va~ina

urethra
blo_od
7764
(4 isolates) wound
va~ina

wound
7760
(3 isolates)

stomach

blood
7714
(3 isolates)

burn

urine
7710
(3 isolates) blood
urine
7463
blood
isolates)
(3
vanna

API Snecies
Identification

s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

enidermidis
euidermidis
enidermidis
enidermidis
enidermidis
enidermidis
euidermidis
hominis
euidermidis
hominis
hominis
e-gidermidis

s.

eoiderm_idis
epidermidis
epidermidis

s.
s.
s.
s.
s.

e_pidermidis
epidermidis
euidermidis
euidermidis
hominis
euidermidis
epidermidis
enid e rmi dis
epidermidis
hominis
euidermidis
hominis
epidermidis
euidermidis

eJlidermidis
euidermidis
epidermidis

No identification
No identification
s. cohnii

Kloos and
Schleifer Species
Identification

s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

euidermidis
enidermidis
enidermidis
enidermidis
enidermidis
enidermidis
epidermidis
euidermidis
euidermidis
epidermidis
euidermidis
enidermidis
enidermidis
epidermidis
euidermidis
epidermidis
euidermidis
e-oidermidis
euidermidis
euidermidis
epti.dermi dis
euidermidis
epidermidis
euidermidis
epidermidis
euidermidis
euidermidi s
euidermidis
eJ)j_dermidi s
epidermidis
euidermidis
eoidermidis
warneri
warneri
warneri
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Table II.

Continued

Code

API Species
Identification

Source

7777

(2 isolates) wound
ear

No identification ·
No identification

urine
7773
(2 isolates) eye

s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

haemolvticus
cohnii

s.
s.
s.
s.

sanronhvticus
eoidermidis

7754

urine

7753

blood
burn

7750

blood
amniotic

(2 isolates)

(2

isol~.tes)

(2 ioolates)

urine
7730
(2 isolates)

7717

_12_ isolates}

blood

{2 isolates)

7520

urine
wound

7473

urine

7763
7762
7757
7724
7700
7664
7574
7570
7563
7430
7270
6463
_6421

urine

(2 isolates)
Misc. codes

caoitis
epidermidis
haemolvticus
haemolvtict:.s
enidermidis
epidermidis
hominis
eoidermidi s

sci uri
No identification

warneri
warneri

No identification
No identification
s. cohnii
s. hominis
s. eJJidermidis
s. hominis
s. hominis
s. enidermidis
No identification
s. sanronhvticus
No identification
s. cohnii
s. sa·oronhvticus

Kloos and
Schleifer Species
Identification

s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

hominis
hominis
hominis
hominis
enidermidis
eoidermidis
hominis
hominis
enidermidis
epidermidis
enidermidis
enidermidis

s._ hominis

s.
s.
s.
s.
s.
s.
No
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

hominis
enidermidi s
epidermidis
saprophyticus
sanronhvticus
hominis
identification
hominis
enidermidis
enidermidis
enidermidis
epidermidis
enidermidis
warneri
enidermidis
simulans
haemolvticus
haemolvticus
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Table II.

Continued

Code

Source

7720
7663
7564
7524
7465
7277
7330
7233
7043
6631
5704
5600
5540

blood

7744
7734
7677
7647
7627
7600
7534
7460
7370
6615

wound

7674
7614
7404
6570

eye

7771

vadna

5740

burn

~~t~
.7624
7_752
742.7

API Species
I den ti fication

s.
No
s.
s.

Kloos and
Schleifer Species
Identification

epidermidis
identification
epidermidis
hominis
No iden ti fica tion
No identification
s. enidermidis
No identification
s. cohnii
s. hominis
s. hominis
s. hominis
s. hominis

s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

s.
s.
No
s.
s.
s.
s.
s.

s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.
s.

enidermidis
epidermidis
hominis
hominis
hominis
epidermidi s
epidermidis
enidermidis
simulans
haemol:vticus

hominis

s.

hominis

epidermidis

No identification

e]:lidermidi s
epidermidis
identification
cohnii
epidermidis
epidermidis
hominis
hominis
No identification
No identification

s.
s.
s.
s.
s.
s.

enidermidis
enidermidis
hominis
sanrophyticus

epidermidi s
hominis
eJ)idermidi s
epidermidi s
warneri
simulans
simulans
haemolyticus
warneri
haemol:vticus
No identification
No identification
No identification

. $.

enidermidis
epidermidis
enidermidis
epl~erm·lals

urethra No identification
No identification
nasaphar:vnx No identification

s.
s.

trachea s. caPitis
umbilicus
No identification

No identification

hominis
hominis

No identification

s.

warneri

I
I
f

I

!t

I
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I
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Table IIT
Agreement and Non-Agreement of Species between Methods of API and Kloos and Schleifer

:

1-K

# of iso-

']??4

12

Code

late a

Agree~ent in Species
Identification by API
and Kloos and Schleifer
species
# of isolates
identification

9

7770

7

6

7764 .

.l.f:

3

7760

3

2

.

7?14
7710
7463

..

????
7773

2
2

??54

2

??53
??50
7730

2
2
2

•

3
3

Non-Agreement in Species
Identification by API
and Kloos and Schleifer
# of isoAPI species
Kloos and Schleilates
identification fer identificatkn

s •. ·enidermidis
s. enidermidis
s. epidermidis
s. epidermidis
s. epidermidis
s. epidermidis

s.
s.
s.
s.

_3_

1
1
1

s.

7717

2

7520

2

7473

2

2

1

1

s.
s.

1
1

enidermidis

s.

enidermidis
epidermidis

s.

canitis

S. haerrolvticus

1

s.
s.

hominis
sciuri
No i.d.

1
.2

~~---

hominis

2

1
1

epidermidis

hominis

cohnii
No i.d.
No i.d.
S. haemolvticus
s. cohnii

1

.

hominis

s.

1
2
2

1

hominis

S.

s.

•·••• ""·"'

saniQ~s

warneri

~

-·--""""

s.
s.
s.
s.

epidermidis
enidermidis
e}:)j_dermidis
epidermidis

s.
s.
s.
s.
s.
s.
s.

warneri
warneri
hominis
hominis
hominis

s.
s.
s.
.
s.
s.

epidermidis
hominis
hominis

epidermidis
hominis

epidermidis
sanronh:vticus

1.\:)

CD

*"""~-~~--~-~~-~---

Table III.

L-K

Code

Misc.

Continued

# of isolates
4?

Agreement in Species
Non-Agreement in Species
Identification by API
Identification by API
and Kloos and Schleifer
and Kloos and Schleifer
species
# of isoAPI species
# of isoKloos and Schleilates
identification
lates
identification fer identificatiot
9
1

s.
s.

enidermidis
hominis
7
1

3
2
1
1
2

1

s.
s.
s.
s.

etiiderm1.dl.s
S. haemo1.vti cus
No i.d.
s. hominis
S. haemolvti cnF;
-S. warne-ri
S. enidermiCft s
~§., haemo lvti cnF;

s..

enidermidis

S..
S.
No
No
No
No

eni de'rmi di
c<tnitis
i.d.
i. d.
i.d ..
i.d.

s·. simulans
S. homi ni F;
No i .c ..
No i.e
s. homini F;
-s. warne-ri
S. si mnl a.ns
S.. haemol vti CUF;
___No_ i.d.

s.. enidermidis

I)

-:s

3
2
2-

s.

hominis
hominis
hominis
cohnii
S. cohnTI
S. cohnii
-& sanrcnhvti ens
S. oonronhvti c us

_No i. d.

R

-~

-

I

I
:

I

w
0

-~~~~-~

.•

~m,~~

~~-~-·~-·•~•--·~~~-••-~--~~-~·~~---------

Table

lV

Distribution of Species by Source of Specimen

~nn-rt!P-

uripe_

Agreement in Species
Identification by API
l
and Kloos and Schleifer
species
# of iso- -# of isolate a
identification
lates ·

2Q

11

Non-Agreement in Species
Identification by API
and Kloos and Schleifer
API species
# of isoKkos and Schleilates
identification fer identift.cation

Is. enidermidis

s.

1

S. enidermi dis
enidermidis
S .. sanronhvticus
s. hominis
s.. enidermidis
s. hominis
s. haemolvticus
No i.d.
s. warneri
No i.d.
s. hominis
s. simulans
No 1.0..
s. saoror>hvticus s. haemolyticus
No i.d.T
No i.d.

1

S. haemolyti cus

s.

1

1
1
2

1
1
1

. blonq

24

q

S. hominis

s. sanronhvtlrus
s . . ·warneri
s. haemclvti cus
s. cani tis
s. cohnii
s. cohnii

4

2
2
1

!S. enidermtdis
1
l
l

1
1

5
2
l
l

2

_s.

sc~ur~

s. nominis
s. ep~dermidis
s. cohniT
s. hominis
s. l'foniinT s
No T.a.
_No ~.d.
No i.d.
No i.d.

hominis
s. noml.nl.s
s. ep~aerrnafs
s. simu!ans
-s. warneri
s. naemolytl.cus
-No 1..a.
-s. warneri
s. s1.mu1ans
--s. naemoiy-·fl. cus
s. nominis
CJJ

.......

Table IV.

Source
wound

Continued

~

of isolates

Agreement in Species
Identification by API
and Kloos and Schleifer
species
# of isolates
identification

s.

9

19

Non-Agreement in Species
Identification by API
and Kloos and Schleifer
Kloos and Sclil.ei;..
'(i of isoAPI species
lates
identification fer :iientlfl cation

enidermidis

!

1
2

'

1
1
3_

s.

s.
s.

epidermidi s
hominis

S. hominis
s. cohnii

s.
s.

enidermidis
warneri

'

eye

8

s.

~

enidermidis
1
1

vagina

6

nominis
S.· cohnii
S. sanronhvticus

s. epidermidis
1>. hominis

~

1

1
,

1

burn

4

s.

1

epidermidis
1
~

No i.d.

s.

nominis

1

No i.d.

s.

homin1 s

1

"··· r.ani tis

No i.d.

1

No i.d.

s.

1

No i.d.

No i._!h

1

ear

2
1

1

fluid

1

1

--

1

umbilicus
nasonharvnx

1

epidermidis
epidermidis

.
warneri

'

1

.,-...,.-~"--

'"··--

'"'·""""~·

··~·..,-,.,·"'"=~

-·"

o-

i

-

enidermidis

s.
s.

.

trachea

epidermidis

s.

1

stomach

-mDnl.-O"tre-

s.

1

3

s. enidermidis
hominis
haemolvticus s. hominis
etiiderm1dis No i.d.

s.
s.
s.

1

urethra

S. enidermidis
s. hominis
s. hominls
S. hominis
S. simulans
S. haemol v-ticus

S. hominis
S. cohnii
s. enidermidis
No i.d.
No i.d.
No i.d.

4
1

-

.

. ...

...-

.~~;r",...-..,-,--.,-=no:mr~~..,..,,...,...,.,.,.,~.-=.~...,-,..,.,.-mtl .,~,...,..,-~....,...,__...,-,-.,.-,-,-'TT11"1':" ..,..-~~
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